Approvals/TGA/XEOMIN, incobotulinumtoxinA, 100 units; purified neurotoxin, free from complexing proteins, Powder for solution for injection Vial

Approved

STANDARD

XEOMIN, incobotulinumtoxinA, 100 units; purified neurotoxin, free from complexing proteins, Powder for solution for injection Vial

Merz Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 0006da5c59871994
Product Name: XEOMIN, incobotulinumtoxinA, 100 units; purified neurotoxin, free from complexing proteins, Powder for solution for injection Vial
Artg Id: 205508
Artg Name: XEOMIN, incobotulinumtoxinA, 100 units; purified neurotoxin, free from complexing proteins, Powder for solution for injection Vial
Sponsor: Merz Australia Pty Ltd
Company Detail Path: /organization/merz-australia-pty-ltd
Artg Date: 2014-03-21
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/ebdddc12478f70d88c242edaa9f8846b.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/46a00ce9a501375df4b7c8ee6281ca63.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

0006da5c59871994

Type

Standard